"MIRO" Molecularly Oriented Immuno-radio-therapy

计划入组 110 人 · 首次发布于 2016 年 3 月 17 日

Miro-randomized Trial for Optimizing a JITAI to Reduce Dietary Lapses in Obesity Treatment

计划入组 204 人 · 首次发布于 2021 年 3 月 5 日

Microbial Restoration in Inflammatory Bowel Diseases

计划入组 120 人 · 首次发布于 2021 年 7 月 21 日

MDR-001

VED-001

VVX-001

Miromatrix Medical Inc.

United States

Pelican Therapeutics, Inc.

United States

The State University of New York

United States

World's First Bioengineered External Liver Assist Device Treats Patient in Groundbreaking Clinical Trial

Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury

Insignis Therapeutics Receives Positive FDA Feedback for Needle-Free Anaphylaxis Treatment, IN-001